Learn to Customize Your Own Options Trading Strategy
This guide will help you evaluate and analyze your trading plan to create a custom options trading strategy tailored to your risk profile and market outlook. Learn how to take your trading to the next level.
Download your FREE Options Strategy Guide Today!

AGY Insider Trading (Allergy Therapeutics)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £10,800
Insider Selling (Last 12 Months): GBX 0

Allergy Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Allergy Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Allergy Therapeutics Share Price & Price History

Current Price: GBX 35.50
Price Change: +0.30 (1.20%)
As of 12/3/2021 01:00 AM ET

This chart shows the closing price history over time for AGY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Which State Is Ranked #1 For Lithium Investors?
The Fraser Institute ran a survey to find the best spot in the world for lithium mining. They researched 77 spots from around the world… and the Nevada Desert won the #1 spot by a landslide. And this small mining company just staked 11,700 acres of mineral claims in Nevada's hottest lithium spot...
See Why This Lithium Stock Could Explode

Allergy Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/10/2021Peter JensenInsiderBuy30,000GBX 36£10,800
11/19/2020Peter JensenInsiderBuy100,000GBX 14£14,000
See Full Table
Insider Selling at Allergy Therapeutics?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Allergy Therapeutics and related companies.

SEC Filings (Institutional Ownership Changes) for Allergy Therapeutics (LON:AGY)

Allergy Therapeutics logo
Allergy Therapeutics plc engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Acarovac MPL, Venomil, Synbiotics, Penicillin Diagnostics, and Peanut. The company also develops allergy vaccines for grass, tree, and house dust mite, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.
Read More on Allergy Therapeutics

Today's Range

Now: GBX 35.50
Low: 35.05
High: 35.50

50 Day Range

MA: GBX 35.92
Low: 33.49
High: 38

52 Week Range

Now: GBX 35.50
Low: 14.11
High: 40.50

Volume

170,823 shs

Average Volume

343,008 shs

Market Capitalization

£227.84 million

P/E Ratio

88.75

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Allergy Therapeutics?

Allergy Therapeutics' top insider investors include:
  1. Peter Jensen (Insider)
The Only Futures Trading Guide You’ll Ever Need
Regardless of your level of futures trading prowess, our Technical Analysis Guide has something to help you succeed in today’s futures markets.
Download your FREE Technical Analysis Trading Guide Today!